Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-427-4 | CAS number: 947-42-2
No effects were noted in the key oral and dermal acute toxicity studies and the LD50 in both was greater than 2000 mg/kg, the highest dose tested.
An acute oral toxicity study was performed in rats according to OECD Test Guideline 401 and in compliance with GLP (Hazelton,1987a). An acute dermal toxicity study was performed in rats according to OECD Test Guideline 402 and in compliance with GLP (Hazelton, 1987b).
There were no remarkable findings or mortalities in either the key oral or dermal acute toxicity studies with diphenylsilanediol. Both studies identified the LD50 to be greater than 2000 mg/kg, the highest dose tested.
Based on the available data diphenylsilanediol does not require classification for acute toxicity according to Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again